Physician profile
Andre Robert Lamothe
NPI 1689100018
$2,129.95
in general payments reported to CMS, 2019-2025
6 companies · $1,396 in 2025
The $1,396 reported for 2025 was more than what 89% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.43 · 2023: $128 · 2024: $586 · 2025: $1,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260 · Travel and Lodging: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.61 |
| Travel and Lodging | $850.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,817.01 | 2023-2025 | |
| Straumann USA LLC | $166.92 | 2023-2025 | |
| Kls-Martin L.P. | $50.68 | 2022-2024 | |
| Nobel Biocare USA | $39.04 | 2023 | Nobelactive |
| Dentsply Sirona INC | $34.32 | 2024 | Astra Tech Implant System |
| Pacira Pharmaceuticals Incorporated | $21.98 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Lamothe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.